Caregivers' Attitudes Toward COVID-19 Vaccination in Children and Adolescents With a History of SARS-CoV-2 Infection.
caregivers
hesitancy
influenza
long covid
papillomavirus
parental
pediatrics
vaccination
Journal
Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492
Informations de publication
Date de publication:
2022
2022
Historique:
received:
01
02
2022
accepted:
03
03
2022
entrez:
25
4
2022
pubmed:
26
4
2022
medline:
26
4
2022
Statut:
epublish
Résumé
Limited data are available on the attitudes of caregivers toward COVID-19 vaccination in children and adolescents with a history of SARS-CoV-2 infection or Long Covid symptoms. The aim of this study was to investigate the vaccine hesitancy among caregivers of children and adolescents with a documented history of SARS-CoV-2 infection and to explore the possible associations between COVID-19 manifestations and the acceptance of the vaccine. Caregivers of children or adolescents with a microbiologically confirmed diagnosis of SARS-CoV-2 infection evaluated in two University Hospitals were interviewed. We were able to contact 132 caregivers and 9 declined to participate. 68 caregivers (56%) were in favor of COVID-19 vaccination for their child. In the multiple logistic regression, child's age (OR 1.17, 95%CI 1.06-1.28) and hospitalization due to COVID-19 (OR 3.25, 95%CI 1.06-9.95) were positively associated with being in favor of COVID-19 vaccination. On the contrary, the occurrence of child's Long Covid was associated with a higher likelihood of being against the vaccination (OR 0.28, 95%CI 0.10-0.80). This preliminary study shows that only about half of the interviewed parents of children and adolescents with a previous SARS-CoV-2 infection are willing to vaccinate them to prevent a repeated COVID-19 infection. These findings might help healthcare workers to provide tailored information to caregivers of children with a previous SARS-CoV-2 infection.
Sections du résumé
Background
UNASSIGNED
Limited data are available on the attitudes of caregivers toward COVID-19 vaccination in children and adolescents with a history of SARS-CoV-2 infection or Long Covid symptoms. The aim of this study was to investigate the vaccine hesitancy among caregivers of children and adolescents with a documented history of SARS-CoV-2 infection and to explore the possible associations between COVID-19 manifestations and the acceptance of the vaccine.
Methods
UNASSIGNED
Caregivers of children or adolescents with a microbiologically confirmed diagnosis of SARS-CoV-2 infection evaluated in two University Hospitals were interviewed.
Results
UNASSIGNED
We were able to contact 132 caregivers and 9 declined to participate. 68 caregivers (56%) were in favor of COVID-19 vaccination for their child. In the multiple logistic regression, child's age (OR 1.17, 95%CI 1.06-1.28) and hospitalization due to COVID-19 (OR 3.25, 95%CI 1.06-9.95) were positively associated with being in favor of COVID-19 vaccination. On the contrary, the occurrence of child's Long Covid was associated with a higher likelihood of being against the vaccination (OR 0.28, 95%CI 0.10-0.80).
Conclusions
UNASSIGNED
This preliminary study shows that only about half of the interviewed parents of children and adolescents with a previous SARS-CoV-2 infection are willing to vaccinate them to prevent a repeated COVID-19 infection. These findings might help healthcare workers to provide tailored information to caregivers of children with a previous SARS-CoV-2 infection.
Identifiants
pubmed: 35463893
doi: 10.3389/fped.2022.867968
pmc: PMC9021633
doi:
Types de publication
Journal Article
Langues
eng
Pagination
867968Informations de copyright
Copyright © 2022 Buonsenso, Valentini, Macchi, Folino, Pensabene, Patria, Agostoni, Castaldi, Lecce, Giannì, Marchisio, Milani and the CHICO Study Group.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Science. 2021 Nov 19;374(6570):913
pubmed: 34793207
J Med Virol. 2021 Apr;93(4):1857-1859
pubmed: 33112002
MMWR Morb Mortal Wkly Rep. 2022 Jan 14;71(2):52-58
pubmed: 35025852
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Curr Pediatr Rev. 2022;18(3):226-236
pubmed: 34931965
Front Public Health. 2021 Sep 28;9:747787
pubmed: 34650953
JAMA Pediatr. 2021 Feb 1;175(2):193-194
pubmed: 32926119
Vaccines (Basel). 2021 Sep 30;9(10):
pubmed: 34696223
JAMA. 2022 Jan 18;327(3):281-283
pubmed: 34928295
Lancet. 2020 Jun 6;395(10239):1771-1778
pubmed: 32410760
N Engl J Med. 2022 Jan 6;386(1):35-46
pubmed: 34752019
Front Immunol. 2021 Mar 19;12:654165
pubmed: 33815415
medRxiv. 2022 Jan 02;:
pubmed: 35018384
N Engl J Med. 2021 Jul 15;385(3):239-250
pubmed: 34043894
BMC Public Health. 2021 Sep 13;21(1):1662
pubmed: 34517848
N Engl J Med. 2020 Jul 23;383(4):334-346
pubmed: 32598831
Acta Paediatr. 2021 Sep;110(9):2578-2580
pubmed: 34157167
Lancet. 2022 Feb 19;399(10326):699-701
pubmed: 35123665
Ital J Pediatr. 2021 Oct 11;47(1):203
pubmed: 34635133
Eur J Pediatr. 2022 Apr;181(4):1597-1607
pubmed: 35000003
Pediatr Pulmonol. 2021 Aug;56(8):2495-2502
pubmed: 34102037
Euro Surveill. 2021 Dec;26(50):
pubmed: 34915975
Pediatrics. 2020 Dec;146(6):
pubmed: 32968031
Front Public Health. 2021 Oct 13;9:752323
pubmed: 34722451
JAMA. 2022 Jan 4;327(1):23-25
pubmed: 34910088
Nature. 2021 Nov;599(7886):546-548
pubmed: 34815580
Acta Paediatr. 2021 Jul;110(7):2208-2211
pubmed: 33835507
medRxiv. 2022 Jan 13;:
pubmed: 35043116
N Engl J Med. 2021 Feb 18;384(7):589-591
pubmed: 33471977
Nature. 2021 Oct;598(7881):393-394
pubmed: 34650244
Eur J Pediatr. 2021 Feb;180(2):307-322
pubmed: 32803422
Pediatr Infect Dis J. 2021 Apr 1;40(4):e146-e150
pubmed: 33464019
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
Eur J Pediatr. 2020 Aug;179(8):1175-1177
pubmed: 32361966
Inflammopharmacology. 2021 Oct;29(5):1357-1360
pubmed: 34279767